Free Newsletter
Mumps outbreak spurs calls for a new vaccine
Health experts say that an outbreak of mumps two years ago among college students occurred even though most of them had received a recommended vaccine. And a number of physicians have concluded that that failure underscores the need for a new vaccine. In the meantime, adding a third dose of the currently used vaccine may be the best way to head off any renewed outbreak.
The outbreak in the Midwest hit thousands of people--making it the worst in almost 20 years. And 84 percent of the patients who knew for sure whether they had been vaccinated had been vaccinated against mumps, according to a study by the Centers for Disease Control and Prevention and state health departments. Researchers believe that a new strain of mumps that originated in the U.K. was probably responsible for the outbreak.
"It may be time to be developing a new vaccine," Pam Shaw, a pediatrician at the University of Kansas Medical Center, tells the Kansas City Star.
- read the report for more
Related Articles:
Chiron pulls MMR vaccine off the market
WHO: Infectious disease a growing threat
Comments
Post new comment
Paid Research Reports
- The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
- New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency
- Stakeholder Opinions: Vaccine antigen delivery technologies - Molecular systems to open new markets
- The Top 10 Contract Research Organizations
- Stakeholder Opinions: Vaccine administration technologies - Beyond needles
- Future Pharmaceutical Industry Trends: Long-term opportunities tempered by short-term challenges





Click here to get the FierceVaccines email newsletter for FREE!
Be the first to comment